FDA green-lights powerful new flu vaccine in world-first
Clinical trials showed it is 27% more effective than conventional flu shots, which have used the same basic technology for over 70 years. The mRNA approach also cuts manufacturing time from 6 months to 2 to 3 months, allowing faster responses to an infectious disease that kills up to 52,000 Americans annually.
You must log in or # to comment.
The approval covers two of the most vulnerable populations for flu—adults aged 50 to 65 and adults aged 65 and up—on the condition that Moderna will run a further clinical trial in the older group.
Bummer it’s not, you know, everyone who wants a flu shot. Because there’s a lot of people who think they can tough out the season and I’m sure a bunch will go to waste.
